Through his “tariff war”, Trump seeks to subvert multilateral institutions and renegotiate trade agreements to (even further) benefit the US

New amendments to patent rules in India will jeopardize the country’s ability to produce generics, dealing a strong blow to access to medicines in both India and other countries of the Global South

Trade delegates and WTO Secretariat celebrate package of documents issued at the end of the Ministerial Conference, yet outlook for Global South remains bleak

As the COVID-19 pandemic turns two, access to medicines movements warn that a recent compromise deal on the TRIPS waiver allegedly outlined by the US, the EU, India and South Africa will not be enough to address existing inequities

Nurses from 28 countries have filed a complaint in the UN alleging human rights violations by EU, UK, Norway, Switzerland, and Singapore for ‘the loss of countless lives’ in the pandemic.

Today we look at the results of a major presidential election in Honduras, an appeal by nurses asking the UN to investigate countries blocking the TRIPS waiver, and more

Today we look at the humanitarian crisis in Tigray as the civil war re-escalates, protests for vaccine equity during Angela Merkel’s visit to the US, and more

Despite attempts by the European Commission to stall discussion on the TRIPS waiver proposal for COVID-19 vaccines, the proposal has inched forward with support from the European Parliament and some parliaments of EU members states

In this show, immunologist Prof. Satyajit Rath sheds light on issues of vaccine equity, possibility of mass inoculation, the need for booster shots and more

Almost 85% of all COVID vaccines administered till date have been in high income and upper-middle income countries. The poorest countries meanwhile have still only received 0.3% of all vaccine doses.

Today we look at an investigation into police killings during the November protests in Uganda, the lockout of ExxonMobil workers in the US, and more

Sangeeta Shashikant from the Third World Network looks at the position of different countries, how pharmaceuticals are profiting from the crisis, and the urgent need for the negotiations to be fast tracked and concluded.